Products for Research Use Only
RegisterLogin

BTdCPU

CAT: 0804-HY-118266-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-118266-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
BTdCPU is a potent heme regulated inhibitor kinase (HRI) activator that promotes eIF2α phosphorylation and induces apoptosis in Dexamethasone (Dex) -resistant cancer cells. BTdCPU can be used in the study of cancers such as multiple myeloma and Dex-resistant multiple myeloma[1][2].
CAS Number
1257423-87-2
Product Name Alternative
BR-941
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; Phosphatase
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Neuroscience-Neurodegeneration
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/btdcpu.html
Purity
99.03
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=C2N=NSC2=C1)NC3=CC=C(C(Cl)=C3)Cl
Molecular Formula
C13H8Cl2N4OS
Molecular Weight
339.20
Precautions
H302, H315, H319, H335
References & Citations
[1]Burwick N, et al. The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma. Leuk Res. 2017 Apr;55:23-32. |[2]Chen T, et al. Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer target. Nat Chem Biol. 2011 Jul 17;7 (9) :610-6.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products

CatalogName
BA2783-10BTdCPU
217337-01EIF2-GTP-tRNAiMet Ternary Complex Inhibitor, BTdCPU (N, N'-diarylurea; translation Initiation Tenrary Complex Inhibitor, 1- (benzo[d][1,2,3]thiadiazol-6-yl) -3- (3,4-dichlorophenyl) urea, BTdCPU, Heme-regulated Inhibitor Kinase Activator, BTdCPU)

Popular Products